Your Location：
Home >
Browse articles >
Salmonella enterica mediated epigenetic promotion of fibrosis is a novel factor in benign prostatic hyperplasia
RESEARCH | Updated：2025-12-13

    • Salmonella enterica mediated epigenetic promotion of fibrosis is a novel factor in benign prostatic hyperplasia

    • “Reporting on the latest research in the field of benign prostatic hyperplasia (BPH), experts have established a novel link between microbial presence and prostatic fibrosis. The study, which provides solutions to address the ineffectiveness of current BPH treatments, verified that Salmonella enterica promotes prostatic fibrosis through ALKBH5-m6A-GPX4-mediated ferroptosis, laying a foundation for the construction of new therapeutic targets and personalized strategies.”
    • Military Medical Research   Vol. 12, Issue 9, Pages: 1350-1368(2025)

    • DOI：10.1186/s40779-025-00614-2    

      CLC：

    • Received：30 December 2024，

      Accepted：29 April 2025，

      Online First：29 May 2025，

      Published：2025-09

    Scan QR Code

  • Cong Zhu, Lu-Yao Li, Ming-Hui Shi, et al. Salmonella enterica mediated epigenetic promotion of fibrosis is a novel factor in benign prostatic hyperplasia[J]. Military Medical Research, 2025, 12(9): 1350-1368. DOI： 10.1186/s40779-025-00614-2.

  •  
  •  

0

Views

0

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021
P. gingivalis in oral-prostate axis exacerbates benign prostatic hyperplasia via IL-6/IL-6R pathway
GPR65 as a potential novel therapeutic target for the treatment of hepatic fibrosis
Coupling Vibration Analysis on Yuxi River Bridge of Wuhu Yangtze River Bridge
Simulation Analysis on Static Performance of EP Solenoid Valves Based on ANSYS

Related Author

Xian-Tao Zeng
Shuang-Ying Wang
Chang-Jiang Qin
Zhi-Yuan Jian
Xian-Tao Zeng
Yu Fan
Tong-Zu Liu
Hang Zheng

Related Institution

Department of Urology, Institute of Urology, Peking University First Hospital, Peking University, The National Urological Cancer Center of China
Evidence-Based Medicine Center, Xiangyang No. 1 People’s Hospital, Hubei University of Medicine
Department of Urology, Wuhan Clinical Research Center of Tumors of the Urinary System and Male Genital Organs, Hubei Key Laboratory of Urinary System Diseases, Zhongnan Hospital of Wuhan University
Department of Urology, Wuhan Third Hospital, Tongren Hospital of Wuhan University
Department of Forensic Medicine, Zhongnan Hospital of Wuhan University
0